JPMorgan Chase & Co’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,748,795
Closed -$321M 5984
2021
Q2
$321M Sell
1,748,795
-515,586
-23% -$94.7M 0.04% 437
2021
Q1
$346M Sell
2,264,381
-2,047,029
-47% -$313M 0.05% 379
2020
Q4
$674M Buy
4,311,410
+111,699
+3% +$17.5M 0.1% 201
2020
Q3
$472M Buy
4,199,711
+374,895
+10% +$42.2M 0.08% 229
2020
Q2
$429M Buy
3,824,816
+870,182
+29% +$97.7M 0.08% 234
2020
Q1
$265M Sell
2,954,634
-1,924,705
-39% -$173M 0.06% 285
2019
Q4
$528M Buy
4,879,339
+115,109
+2% +$12.4M 0.1% 206
2019
Q3
$467M Buy
4,764,230
+1,699,323
+55% +$166M 0.09% 229
2019
Q2
$387M Sell
3,064,907
-1,676,974
-35% -$211M 0.08% 265
2019
Q1
$641M Buy
4,741,881
+380,208
+9% +$51.4M 0.13% 160
2018
Q4
$425M Buy
4,361,673
+791,885
+22% +$77.1M 0.1% 208
2018
Q3
$496M Buy
3,569,788
+2,109,596
+144% +$293M 0.1% 211
2018
Q2
$181M Buy
1,460,192
+643,387
+79% +$79.9M 0.04% 440
2018
Q1
$91M Sell
816,805
-98,088
-11% -$10.9M 0.02% 632
2017
Q4
$109M Sell
914,893
-879,832
-49% -$105M 0.02% 560
2017
Q3
$248M Buy
1,794,725
+482,798
+37% +$66.8M 0.05% 337
2017
Q2
$160M Sell
1,311,927
-1,758,935
-57% -$214M 0.04% 433
2017
Q1
$372M Buy
3,070,862
+1,354,818
+79% +$164M 0.09% 229
2016
Q4
$210M Sell
1,716,044
-3,924,465
-70% -$480M 0.05% 352
2016
Q3
$691M Buy
5,640,509
+741,568
+15% +$90.9M 0.17% 123
2016
Q2
$572M Sell
4,898,941
-208,444
-4% -$24.3M 0.14% 151
2016
Q1
$711M Buy
5,107,385
+266,270
+6% +$37.1M 0.18% 124
2015
Q4
$923M Buy
4,841,115
+66,466
+1% +$12.7M 0.23% 87
2015
Q3
$747M Sell
4,774,649
-535,516
-10% -$83.7M 0.2% 107
2015
Q2
$960M Sell
5,310,165
-226,771
-4% -$41M 0.23% 82
2015
Q1
$960M Sell
5,536,936
-1,006,884
-15% -$174M 0.22% 89
2014
Q4
$1.21B Sell
6,543,820
-225,216
-3% -$41.7M 0.28% 68
2014
Q3
$1.12B Sell
6,769,036
-289,020
-4% -$47.9M 0.27% 70
2014
Q2
$1.1B Sell
7,058,056
-299,755
-4% -$46.8M 0.28% 67
2014
Q1
$1.12B Buy
7,357,811
+1,199,641
+19% +$183M 0.31% 61
2013
Q4
$818M Buy
6,158,170
+1,069,078
+21% +$142M 0.23% 91
2013
Q3
$591M Buy
5,089,092
+1,319,619
+35% +$153M 0.18% 125
2013
Q2
$348M Buy
+3,769,473
New +$348M 0.11% 209